Manufacturers Life Insurance Company, The Oramed Pharmaceuticals Inc. Transaction History

Manufacturers Life Insurance Company, The

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$3.72 - $9.0 $54,970 - $132,993	-14,777 Closed	0 $0
Q1 2022 Aug 11, 2023	BUY	$8.19 - $13.89 $121,023 - $205,252	14,777 New	14,777 $127,000
Q1 2022 May 20, 2022	SELL	$8.19 - $13.89 $10,335 - $17,529	-1,262 Reduced 7.87%	14,777 $128,000
Q4 2021 Feb 16, 2022	SELL	$12.98 - $29.75 $1,869 - $4,284	-144 Reduced 0.89%	16,039 $229,000
Q3 2021 Nov 12, 2021	BUY	$12.13 - $23.82 $2,838 - $5,573	234 Added 1.47%	16,183 $356,000
Q2 2021 Aug 12, 2021	BUY	$8.34 - $14.59 $133,014 - $232,695	15,949 New	15,949 $213,000

7.4M

2.1K

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $92.4M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.